| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Magnetic Resonance Imaging | 22 | 2021 | 6551 | 1.48 | Why? |
| High-Intensity Focused Ultrasound Ablation | 5 | 2018 | 19 | 1.45 | Why? |
| Magnetic Resonance Imaging, Interventional | 5 | 2018 | 38 | 1.28 | Why? |
| Fetus | 2 | 2017 | 484 | 1.05 | Why? |
| Prostate | 2 | 2018 | 283 | 0.74 | Why? |
| Contrast Media | 8 | 2018 | 1011 | 0.73 | Why? |
| Thyroid Nodule | 1 | 2019 | 70 | 0.73 | Why? |
| Liposarcoma | 1 | 2018 | 17 | 0.72 | Why? |
| Osteoma, Osteoid | 1 | 2017 | 6 | 0.71 | Why? |
| Prenatal Diagnosis | 2 | 2017 | 345 | 0.70 | Why? |
| Neoadjuvant Therapy | 3 | 2019 | 554 | 0.70 | Why? |
| Elasticity Imaging Techniques | 2 | 2019 | 194 | 0.69 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2018 | 56 | 0.69 | Why? |
| Nervous System Malformations | 1 | 2017 | 43 | 0.69 | Why? |
| Thymus Neoplasms | 1 | 2018 | 69 | 0.67 | Why? |
| Heart | 4 | 2021 | 1791 | 0.65 | Why? |
| Image Enhancement | 3 | 2018 | 177 | 0.65 | Why? |
| Breast | 4 | 2018 | 290 | 0.61 | Why? |
| Fetal Diseases | 1 | 2017 | 182 | 0.59 | Why? |
| Tomography, X-Ray Computed | 16 | 2021 | 25144 | 0.57 | Why? |
| Carcinoma, Hepatocellular | 5 | 2019 | 1222 | 0.56 | Why? |
| Ultrasonography, Mammary | 1 | 2013 | 31 | 0.52 | Why? |
| Bone Neoplasms | 1 | 2017 | 287 | 0.52 | Why? |
| Prostatic Neoplasms | 4 | 2018 | 1637 | 0.51 | Why? |
| Chemoembolization, Therapeutic | 3 | 2019 | 144 | 0.50 | Why? |
| Breast Diseases | 1 | 2013 | 75 | 0.48 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.47 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.45 | Why? |
| Liver Neoplasms | 5 | 2019 | 1666 | 0.43 | Why? |
| Epirubicin | 2 | 2019 | 21 | 0.40 | Why? |
| Foreign-Body Migration | 1 | 2009 | 25 | 0.39 | Why? |
| Prostate-Specific Antigen | 3 | 2018 | 213 | 0.36 | Why? |
| Blood Flow Velocity | 2 | 2018 | 193 | 0.33 | Why? |
| Cone-Beam Computed Tomography | 2 | 2018 | 118 | 0.33 | Why? |
| Neoplasm Grading | 2 | 2018 | 400 | 0.32 | Why? |
| Blood Vessel Prosthesis Implantation | 2 | 2018 | 226 | 0.29 | Why? |
| Breast Neoplasms | 4 | 2018 | 3633 | 0.28 | Why? |
| Ultrasonography, Interventional | 3 | 2018 | 560 | 0.27 | Why? |
| Polyethylene Glycols | 2 | 2019 | 574 | 0.27 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2020 | 665 | 0.25 | Why? |
| Neoplasm Staging | 3 | 2019 | 1999 | 0.24 | Why? |
| Meglumine | 3 | 2018 | 26 | 0.24 | Why? |
| Peripheral Arterial Disease | 2 | 2018 | 471 | 0.23 | Why? |
| Antibiotics, Antineoplastic | 2 | 2019 | 128 | 0.22 | Why? |
| Intra-Abdominal Fat | 2 | 2020 | 227 | 0.21 | Why? |
| Mass Chest X-Ray | 1 | 2020 | 68 | 0.21 | Why? |
| Subcutaneous Fat | 1 | 2020 | 94 | 0.20 | Why? |
| Organometallic Compounds | 3 | 2018 | 206 | 0.19 | Why? |
| Image-Guided Biopsy | 2 | 2018 | 185 | 0.19 | Why? |
| Balloon Occlusion | 1 | 2019 | 39 | 0.19 | Why? |
| Common Bile Duct | 1 | 2018 | 21 | 0.19 | Why? |
| Postmortem Changes | 1 | 2019 | 133 | 0.19 | Why? |
| Chemotherapy, Adjuvant | 2 | 2019 | 606 | 0.19 | Why? |
| Iopamidol | 1 | 2018 | 19 | 0.19 | Why? |
| Liver Cirrhosis | 1 | 2010 | 1810 | 0.18 | Why? |
| Essential Tremor | 1 | 2018 | 19 | 0.18 | Why? |
| Heart Septum | 1 | 2018 | 29 | 0.18 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.18 | Why? |
| Hospitals, Military | 1 | 2020 | 205 | 0.18 | Why? |
| Spinal Nerve Roots | 1 | 2017 | 8 | 0.18 | Why? |
| Predictive Value of Tests | 8 | 2019 | 9537 | 0.18 | Why? |
| Popliteal Artery | 1 | 2018 | 32 | 0.18 | Why? |
| Forensic Pathology | 1 | 2019 | 109 | 0.18 | Why? |
| Lipoma | 1 | 2018 | 15 | 0.18 | Why? |
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 30 | 0.18 | Why? |
| Placentation | 1 | 2017 | 11 | 0.18 | Why? |
| Adenomyosis | 1 | 2017 | 1 | 0.18 | Why? |
| Abdominal Injuries | 1 | 2018 | 72 | 0.18 | Why? |
| Ablation Techniques | 1 | 2018 | 54 | 0.18 | Why? |
| Thalamus | 1 | 2018 | 75 | 0.17 | Why? |
| Ventral Thalamic Nuclei | 1 | 2017 | 4 | 0.17 | Why? |
| Thyroid Dysgenesis | 1 | 2016 | 4 | 0.17 | Why? |
| Diffusion Tensor Imaging | 1 | 2017 | 125 | 0.17 | Why? |
| Lung | 6 | 2021 | 31049 | 0.17 | Why? |
| Cholecystectomy, Laparoscopic | 1 | 2018 | 120 | 0.17 | Why? |
| Multimodal Imaging | 2 | 2019 | 534 | 0.17 | Why? |
| Parathyroid Glands | 1 | 2016 | 27 | 0.17 | Why? |
| Prospective Studies | 11 | 2021 | 43301 | 0.17 | Why? |
| Radiographic Image Enhancement | 1 | 2017 | 89 | 0.16 | Why? |
| Myocardium | 3 | 2018 | 2323 | 0.16 | Why? |
| Upper Extremity | 1 | 2019 | 193 | 0.16 | Why? |
| Embolism | 1 | 2018 | 136 | 0.16 | Why? |
| Tremor | 1 | 2017 | 89 | 0.16 | Why? |
| Cancer Pain | 1 | 2018 | 91 | 0.16 | Why? |
| Blood Vessels | 1 | 2018 | 228 | 0.16 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2016 | 907 | 0.16 | Why? |
| Female | 40 | 2021 | 380317 | 0.16 | Why? |
| Coronary Circulation | 1 | 2018 | 188 | 0.15 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.15 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 869 | 0.15 | Why? |
| Pregnancy Trimester, Second | 1 | 2017 | 314 | 0.15 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.15 | Why? |
| Iodine | 1 | 2017 | 116 | 0.15 | Why? |
| Feasibility Studies | 4 | 2019 | 3467 | 0.15 | Why? |
| Aorta, Thoracic | 1 | 2018 | 271 | 0.15 | Why? |
| Pregnancy Trimester, Third | 1 | 2017 | 445 | 0.15 | Why? |
| Myocardial Perfusion Imaging | 1 | 2018 | 218 | 0.15 | Why? |
| Aorta | 1 | 2018 | 355 | 0.15 | Why? |
| Lipase | 1 | 2016 | 153 | 0.15 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2018 | 161 | 0.14 | Why? |
| Humans | 59 | 2021 | 930598 | 0.14 | Why? |
| Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.14 | Why? |
| Elastic Modulus | 1 | 2013 | 22 | 0.14 | Why? |
| Multidetector Computed Tomography | 1 | 2017 | 307 | 0.13 | Why? |
| Sensitivity and Specificity | 9 | 2020 | 22971 | 0.13 | Why? |
| Carotid Artery Diseases | 1 | 2016 | 251 | 0.13 | Why? |
| Myocarditis | 2 | 2021 | 2731 | 0.13 | Why? |
| Urinary Bladder Neoplasms | 1 | 2020 | 614 | 0.13 | Why? |
| Biopsy | 3 | 2019 | 2811 | 0.13 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.13 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.12 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.12 | Why? |
| Ultrasonography, Prenatal | 1 | 2017 | 471 | 0.12 | Why? |
| Middle Aged | 33 | 2021 | 270681 | 0.12 | Why? |
| Drug Carriers | 1 | 2019 | 590 | 0.12 | Why? |
| Signal-To-Noise Ratio | 3 | 2018 | 217 | 0.12 | Why? |
| Prediabetic State | 1 | 2015 | 200 | 0.12 | Why? |
| Male | 33 | 2021 | 367725 | 0.12 | Why? |
| Insulin-Secreting Cells | 1 | 2015 | 273 | 0.12 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.12 | Why? |
| Adiposity | 1 | 2015 | 329 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2016 | 572 | 0.12 | Why? |
| Cardiomyopathies | 1 | 2021 | 997 | 0.11 | Why? |
| Chi-Square Distribution | 2 | 2015 | 961 | 0.11 | Why? |
| Aged | 27 | 2021 | 215776 | 0.11 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.11 | Why? |
| Pancreas | 1 | 2015 | 398 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Gadolinium DTPA | 1 | 2010 | 45 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Follow-Up Studies | 6 | 2021 | 17020 | 0.11 | Why? |
| Diagnostic Imaging | 1 | 2019 | 1044 | 0.11 | Why? |
| Uterine Cervical Neoplasms | 1 | 2019 | 842 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.10 | Why? |
| Lymphadenopathy | 1 | 2016 | 444 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2019 | 902 | 0.10 | Why? |
| Autopsy | 2 | 2019 | 3495 | 0.10 | Why? |
| Treatment Outcome | 9 | 2021 | 51732 | 0.10 | Why? |
| Adult | 24 | 2021 | 244371 | 0.10 | Why? |
| Neurosurgical Procedures | 2 | 2018 | 1738 | 0.10 | Why? |
| Pediatric Obesity | 1 | 2015 | 492 | 0.10 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.10 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.09 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Endovascular Procedures | 1 | 2018 | 1302 | 0.09 | Why? |
| Liver | 3 | 2019 | 4007 | 0.09 | Why? |
| Microspheres | 2 | 2019 | 261 | 0.08 | Why? |
| Regional Blood Flow | 2 | 2018 | 172 | 0.08 | Why? |
| Placenta | 1 | 2017 | 1531 | 0.08 | Why? |
| Perfusion | 2 | 2018 | 254 | 0.08 | Why? |
| Pregnancy | 3 | 2017 | 23879 | 0.08 | Why? |
| Solitary Pulmonary Nodule | 1 | 2007 | 83 | 0.08 | Why? |
| Fibroadenoma | 1 | 2005 | 3 | 0.08 | Why? |
| Ultrasonography | 3 | 2017 | 4409 | 0.08 | Why? |
| Membrane Proteins | 1 | 2016 | 1733 | 0.08 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.07 | Why? |
| Carcinoma, Lobular | 1 | 2005 | 62 | 0.07 | Why? |
| Computer Systems | 2 | 2017 | 255 | 0.07 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.07 | Why? |
| Carcinoma in Situ | 1 | 2005 | 58 | 0.07 | Why? |
| Neoplasms, Multiple Primary | 1 | 2005 | 61 | 0.07 | Why? |
| Xerophthalmia | 1 | 2003 | 6 | 0.07 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.07 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2005 | 149 | 0.07 | Why? |
| Skin Diseases | 1 | 2020 | 2509 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.06 | Why? |
| Italy | 4 | 2020 | 38444 | 0.06 | Why? |
| Xerostomia | 1 | 2003 | 45 | 0.06 | Why? |
| Imaging, Three-Dimensional | 2 | 2018 | 680 | 0.06 | Why? |
| Genetic Variation | 1 | 2016 | 3919 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Reproducibility of Results | 4 | 2021 | 11304 | 0.06 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.06 | Why? |
| Ichthyosis | 1 | 2020 | 35 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| Heart Ventricles | 1 | 2009 | 1139 | 0.05 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Shoulder Injuries | 1 | 2019 | 13 | 0.05 | Why? |
| Elbow Joint | 1 | 2019 | 27 | 0.05 | Why? |
| Response Evaluation Criteria in Solid Tumors | 1 | 2019 | 37 | 0.05 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
| Wrist Injuries | 1 | 2019 | 37 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| ROC Curve | 3 | 2020 | 6024 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.05 | Why? |
| Cholangiography | 1 | 2018 | 19 | 0.05 | Why? |
| Wrist Joint | 1 | 2019 | 34 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Shoulder Joint | 1 | 2019 | 57 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2020 | 391 | 0.05 | Why? |
| Dyspareunia | 1 | 2017 | 15 | 0.05 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.05 | Why? |
| Dysmenorrhea | 1 | 2017 | 17 | 0.05 | Why? |
| Tissue Adhesions | 1 | 2017 | 33 | 0.04 | Why? |
| Organ Sparing Treatments | 1 | 2018 | 91 | 0.04 | Why? |
| Echo-Planar Imaging | 1 | 2017 | 27 | 0.04 | Why? |
| Whole Body Imaging | 1 | 2018 | 116 | 0.04 | Why? |
| Dermatitis | 1 | 2020 | 188 | 0.04 | Why? |
| Diffusion | 1 | 2017 | 73 | 0.04 | Why? |
| Fibrosis | 2 | 2016 | 800 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.04 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.04 | Why? |
| Hyperemia | 1 | 2017 | 62 | 0.04 | Why? |
| Extracellular Space | 1 | 2016 | 26 | 0.04 | Why? |
| Tumor Burden | 1 | 2019 | 369 | 0.04 | Why? |
| Rome | 1 | 2019 | 497 | 0.04 | Why? |
| Carotid Artery, Common | 1 | 2016 | 49 | 0.04 | Why? |
| Hyperparathyroidism | 1 | 2016 | 38 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Phantoms, Imaging | 1 | 2016 | 146 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Magnetic Resonance Angiography | 1 | 2017 | 282 | 0.04 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 317 | 0.04 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 237 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Carotid Intima-Media Thickness | 1 | 2016 | 179 | 0.04 | Why? |
| Adolescent | 5 | 2019 | 86841 | 0.04 | Why? |
| Body Mass Index | 2 | 2020 | 4306 | 0.04 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.04 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.04 | Why? |
| Automation | 1 | 2016 | 429 | 0.03 | Why? |
| Pulmonary Artery | 1 | 2021 | 803 | 0.03 | Why? |
| Glucose Tolerance Test | 1 | 2015 | 238 | 0.03 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Urticaria | 1 | 2020 | 472 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Particle Size | 1 | 2019 | 1052 | 0.03 | Why? |
| Death, Sudden, Cardiac | 1 | 2018 | 522 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.03 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2018 | 663 | 0.03 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2016 | 881 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Exanthema | 1 | 2020 | 1097 | 0.03 | Why? |
| Brain | 2 | 2018 | 5133 | 0.03 | Why? |
| Lung Neoplasms | 1 | 2007 | 3228 | 0.03 | Why? |
| Military Personnel | 1 | 2020 | 1097 | 0.03 | Why? |
| User-Computer Interface | 1 | 2017 | 1068 | 0.03 | Why? |
| Fasting | 1 | 2015 | 555 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Insulin Resistance | 1 | 2015 | 669 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Linear Models | 1 | 2015 | 1914 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Kidney Failure, Chronic | 1 | 2003 | 3222 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Psoriasis | 1 | 2020 | 1739 | 0.02 | Why? |
| Insulin | 1 | 2015 | 1316 | 0.02 | Why? |
| Laparoscopy | 1 | 2017 | 1532 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Phenotype | 1 | 2016 | 4037 | 0.02 | Why? |
| Software | 1 | 2016 | 2501 | 0.02 | Why? |
| Vehicle Emissions | 1 | 2007 | 328 | 0.02 | Why? |
| Observer Variation | 1 | 2007 | 622 | 0.02 | Why? |
| Police | 1 | 2007 | 243 | 0.02 | Why? |
| Salivary Glands, Minor | 1 | 2003 | 16 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2016 | 3444 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2015 | 5440 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Atrophy | 1 | 2003 | 192 | 0.02 | Why? |
| Hepatitis C Antibodies | 1 | 2003 | 120 | 0.02 | Why? |
| Odds Ratio | 1 | 2015 | 5861 | 0.02 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2016 | 4027 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2016 | 7220 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Mammography | 1 | 2005 | 410 | 0.01 | Why? |
| Statistics as Topic | 1 | 2003 | 370 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Blood Glucose | 1 | 2015 | 3642 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Tears | 1 | 2003 | 400 | 0.01 | Why? |
| Heart Diseases | 1 | 2016 | 3503 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Hepacivirus | 1 | 2003 | 1509 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Risk Assessment | 1 | 2016 | 25439 | 0.01 | Why? |
| Clinical Competence | 1 | 2007 | 3263 | 0.01 | Why? |
| Biomarkers | 1 | 2015 | 23361 | 0.01 | Why? |
| Radiography, Thoracic | 1 | 2007 | 5486 | 0.01 | Why? |
| Occupational Exposure | 1 | 2007 | 4742 | 0.01 | Why? |
| Saliva | 1 | 2003 | 4679 | 0.01 | Why? |
| Renal Dialysis | 1 | 2003 | 4358 | 0.00 | Why? |
| Child | 1 | 2015 | 70012 | 0.00 | Why? |